This company has been acquired
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Cardiovascular Systems Gestion
Gestion contrôle des critères 3/4
Informations clés
Scott Ward
Directeur général
US$4.3m
Rémunération totale
Pourcentage du salaire du PDG | 16.1% |
Durée du mandat du directeur général | 6.7yrs |
Propriété du PDG | 1.9% |
Durée moyenne d'occupation des postes de direction | 3.9yrs |
Durée moyenne du mandat des membres du conseil d'administration | 6.2yrs |
Mises à jour récentes de la gestion
Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Recent updates
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate
Feb 03We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely
Oct 12Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Aug 03Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?
Oct 09At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?
Sep 18Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?
Jun 24Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Jun 03We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow
Apr 29Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain
Feb 10Cardiovascular Systems misses on revenue
Feb 03Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares
Dec 11Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
Nov 06Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Dec 31 2022 | n/a | n/a | -US$38m |
Sep 30 2022 | n/a | n/a | -US$39m |
Jun 30 2022 | US$4m | US$699k | -US$37m |
Mar 31 2022 | n/a | n/a | -US$33m |
Dec 31 2021 | n/a | n/a | -US$29m |
Sep 30 2021 | n/a | n/a | -US$20m |
Jun 30 2021 | US$4m | US$665k | -US$13m |
Mar 31 2021 | n/a | n/a | -US$23m |
Dec 31 2020 | n/a | n/a | -US$20m |
Sep 30 2020 | n/a | n/a | -US$24m |
Jun 30 2020 | US$5m | US$628k | -US$27m |
Mar 31 2020 | n/a | n/a | -US$11m |
Dec 31 2019 | n/a | n/a | -US$7m |
Sep 30 2019 | n/a | n/a | -US$3m |
Jun 30 2019 | US$5m | US$670k | -US$255k |
Mar 31 2019 | n/a | n/a | US$2m |
Dec 31 2018 | n/a | n/a | US$2m |
Sep 30 2018 | n/a | n/a | US$782k |
Jun 30 2018 | US$3m | US$650k | US$2m |
Mar 31 2018 | n/a | n/a | -US$1m |
Dec 31 2017 | n/a | n/a | -US$3m |
Sep 30 2017 | n/a | n/a | -US$2m |
Jun 30 2017 | US$4m | US$630k | -US$2m |
Mar 31 2017 | n/a | n/a | -US$7m |
Dec 31 2016 | n/a | n/a | -US$28m |
Sep 30 2016 | n/a | n/a | -US$45m |
Jun 30 2016 | US$908k | US$363k | -US$56m |
Rémunération vs marché: Scott's total compensation ($USD4.34M) is about average for companies of similar size in the US market ($USD3.84M).
Rémunération et revenus: Scott's compensation has increased whilst the company is unprofitable.
PDG
Scott Ward (62 yo)
6.7yrs
Titularisation
US$4,344,399
Compensation
Mr. Scott Raymond Ward, MS, B.Sc., has been the Chief Executive Officer and President of Cardiovascular Systems Inc. since August 15, 2016 and served as an Interim Chief Executive Officer and Interim Presi...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chairman | 6.7yrs | US$4.34m | 1.92% $ 16.2m | |
Chief Financial Officer | 5.2yrs | US$1.32m | 0.41% $ 3.5m | |
General Counsel & Corporate Secretary | 8.4yrs | US$1.11m | 0.35% $ 3.0m | |
Chief Compliance Officer | 5.8yrs | US$943.21k | 0.27% $ 2.3m | |
Vice President of Quality & Operations | 1.3yrs | pas de données | pas de données | |
Vice President of Investor Relations & Corporate Communications | no data | pas de données | pas de données | |
Vice President of Marketing | 1.3yrs | pas de données | pas de données | |
Vice President of US Sales | 1.3yrs | pas de données | pas de données | |
Chief Human Resources Officer | 3.9yrs | pas de données | 0.20% $ 1.7m | |
Chief Medical Officer | 1.1yrs | pas de données | pas de données |
3.9yrs
Durée moyenne de l'emploi
54yo
Âge moyen
Gestion expérimentée: CSII's management team is considered experienced (3.9 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chairman | 9.4yrs | US$4.34m | 1.92% $ 16.2m | |
Lead Independent Director | 14.2yrs | US$241.64k | 0.072% $ 606.8k | |
Independent Director | 8.2yrs | US$200.00k | 0.022% $ 189.0k | |
Independent Director | 6.2yrs | US$220.00k | 0.029% $ 248.2k | |
Independent Director | 2.7yrs | US$200.00k | 0% $ 0 | |
Independent Director | 3.8yrs | US$210.00k | 0.0017% $ 14.0k | |
Independent Director | 3.4yrs | US$212.00k | 0.0075% $ 63.0k |
6.2yrs
Durée moyenne de l'emploi
62yo
Âge moyen
Conseil d'administration expérimenté: CSII's board of directors are considered experienced (6.2 years average tenure).